Metabolism of pamaqueside, a cholesterol absorption inhibitor, in Long-Evans rat: effect of bile duct cannulation on absorption

References

• AKA°, T., Kam, H., KANAOKA M., HATTORI, M. and KOBASHI, K., 1998, Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb, from Panax ginseng. Journal of Pharmacy and Pharmacology, 1155–1160.
   Google Scholar
• DALVIE, D. K., KHOSLA, N. B., NAVETTA, K. A. and BRIGHTY, K. E., 1996, Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague—Dawley rats and Beagle dogs: effect of bile duct cannulation on excretion pathways. Drug Metabolism and Disposition, 24, 1231–1240.
   PubMed Web of Science ®Google Scholar
• DENINNO, M. P., MCCARTHY, P. A., DUPLANTIER, K. C., ELLER, C., ETIENNE, J. B., ZAWISTOSKI, M. P., BANGERTER, F.-W., CHANDLER, C. E., MOREHOUSE, L. A., SUGARMAN, E. D., WILKINS, R. W., WOODY, H. A. and ZACCARO, L. M., 1997, Steroidal glycoside cholesterol absorption inhibitors. Journal of Medicinal Chemistry, 40,2547–2554.
   Google Scholar
• FELDMAN, S. and GIBALDI M., 1969, Physiologic surface active agents and drug absorption. I. Effect of sodium taurodeoxycholate on the salicylate transfer across the everted rat intestine. Journal of Pharmaceutical Sciences, 58, 425–428.
   Google Scholar
• FOUDA, H. G., AVERY, M. and NAVETTA, K., 1993, Simultaneous hplc-radioactivity and mass spectrometry monitoring. A drug metabolism application. Paper presented at the American Society of Mass Spectrometry Conference, 29 May, San Francisco, CA.
   Google Scholar
• Gomm, B. R., 1990, Intestinal microflora : metabolism of drugs and carcinogens. Annals of Medicine, 22, 43–48.
   PubMed Web of Science ®Google Scholar
• HARWOOD, H. J., JR, CHANDLER, C. E., PELLARIN, L. D., BANGERTER, F.-W., WllAuss, R. W., LONG, C. A., COSGROVE, P. G., MALINOW, M. R., MARZETTA, C. A., PETTINI, J. L., SAVOY, Y. E. and MAYNE, J. T., 1993, Pharmacological consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin 13-tigogenin cellobioside. Journal of Lipid Research, 34, 377–395.
   Google Scholar
• HASELWOOD, G. A. D., 1967, Bile salt evolution. Journal of Lipid Research, 8, 535–550.
   PubMed Web of Science ®Google Scholar
• Hai M. J., 1995, Carbohydrate metabolism. In M. J. Hill (ed.), Role of Gut Microflora in Human Toxicology and Pharmacology (London: Taylor & Francis), pp. 95–104.
   Google Scholar
• HUTT, A. J. and CALDWELL, J., 1990, Amino acid conjugation. In G. J. Mulder (ed.), Conjugation Reactions in Drug Metabolism (London: Taylor & Francis), pp. 273–305.
   Google Scholar
• IKEDA, I. and SUGANO, M., 1983, Some aspects of mechanism of inhibition of cholesterol absorption by fi-sitosterol. Biochimica et Biophysica Acta, 732, 651–658.
   PubMed Web of Science ®Google Scholar
• KANAOKA M., AKA°, T. and KOBASHI, K., 1994, Metabolism of ginseng saponins, ginsenosides by human intestinal flora. Journal of Traditional Medicine, 11, 241–245.
   Google Scholar
• KARIKURA, M., MIYASE, T., TANIZAWA, H., TAKINO, Y., TANIYAMA, T. and HAYASHI, T., 1990, Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb, in the large intestine of rats. Chemical Pharmaceutical Bulletin, 38, 2859–2861.
   PubMed Web of Science ®Google Scholar
• KAIUKURA, M., MIYASE, T., TANIZAWA, H., TANIYAMA, T. and TAKINO, Y., 1991, Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the de-composition modes of ginsnosides-Rb, and -Rb, in the digestive tract of rats. Chemical and Pharmaceutical Bulletin, 39, 2357–2361.
   PubMed Web of Science ®Google Scholar
• KIIVIURA, T., SEZAKI, H. and KAKEMI, K., 1972, Effects of bile salts on the gastrointestinal absorption of drugs. IV. Site of intestinal absorption of sodium taurocholate and its consequence on drug absorption in rats. Chemical Pharmaceutical Bulletin, 20, 1656–1662.
   Google Scholar
• KLAASEN C. D. and WATKINTS, J. B., 1984, Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacological Reviews, 36, 1–67.
   PubMed Web of Science ®Google Scholar
• LENNERN/^Z. S, H. and REGARDH, C.-G., 1993, Evidence for an interaction between the b-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration—time profile. Pharmaceutical Research, 10, 879–883.
   Google Scholar
• MALINOW, M. R., 1985, Effects of synthetic glycosides on cholesterol absorption. Annals of New York Academy of Sciences, 454, 23–27.
   PubMed Web of Science ®Google Scholar
• MALINOW, M. R., GARDNER, J. O., NELSON, J. T., MCLAUGHLIN, P., UPSON, B. and AIGNER -HELD, R. 1986, Effects of a and /3-tigogenin cellobiosides on cholesterol absorption. Steroids, 48, 197–211.
   Google Scholar
• MALINOW, M. R., MCLAUGHLIN, P. and STAFFORD, C., 1978, Prevention of hypercholeterolemia in monkeys by digitonin. American Journal of Clinical Nutrition, 31, 814–818.
   PubMed Web of Science ®Google Scholar
• MCCARTHY, P. A., DENINNO, M. P., MOREHOUSE, L. A., CHANDLER. C. E., BANGERTER, F.-W., WILSON, T. C., URBAN, F. J., WALINSKY S. W., COSGROVE, P. G., DUPLANTER, K., ETIENNE, J. B., FOWLER, M. A., LAMBERT, J. F., O'DONNELL, J. P., PEZZULLO S. L., WATSON, JR, H. A., WILKINS, R. W., ZACCARO, L. M. and ZAWISTOSKI, M. P., 1996,11-Ketotigogenin cellobioside (pamaqueside): a potent cholesterol absorption inhibitor in the hamster. Journal of Medicinal Chemistry, 39, 1935–1937.
   Google Scholar
• MIYAZAKI, S., INOUE, H., YAMAHIRA, T. and NADAI, T., 1979, Interaction of drugs with bile components. I. Effects of bile salts on the dissolution behaviour of indomethacin and phenylbutazone. Chemical and Pharmaceutical Bulletin, 27, 2468–2472.
   PubMed Web of Science ®Google Scholar
• MOREHOUSE, L. A., BANGERTER, F.-W., DENINNO, M. P., INSKEEP, P. B., MCCARTHY, P. A., PETTINI, J., SAVOY, Y. E., SUGARMAN, E. D., WILKINS, R. W., WILSON, T. C., WOODY, H. A., ZACCARO, L. M. and CHANDLER, C. E., 1999, Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of absorption. Journal of Lipid Research, 40, 464–474.
   Google Scholar
• PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Klaassen, M. 0. Amdur and J. Duoll (eds), Casarett and Doull' s Toxicology: The Bask Science of Poisons, 5th edn (New York: McGraw-Hill), pp. 113–186.
   Google Scholar
• SHIRLEY, M., BENNANI, Y. L., BOEHM, M. F., BREAU, A. P., PATHIRANA C. and ULm, E. H., 1996, Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14,-dihydro-9-cis-retinoic acid and its taurine conjugate. Drug Metabolism and Disposition, 24, 293–302.
   Google Scholar
• SHIRLEY, M. A., GUAN, X., KAISER, D. G., HALSTEAD, G. W. and BAILLIE, T. A., 1994, Taurine conjugation of ibuprofen in humans and rat liver in vitro. Relationship to metabolic chiral inversion. Journal of Pharmacology and Experimental Therapeutics, 269, 1166–1175.
   PubMed Web of Science ®Google Scholar
• SUTTLE, A. B. and BROUWER, K. L. R., 1994, Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat. Drug Metabolism and Disposition, 22, 224–232.
   PubMed Web of Science ®Google Scholar
• STRAUB, K. M., RUDEWICZ, P. and GRAVIE, C., 1987, Metabolic mapping of drugs: rapid screening techniques for xenobiotic metabolites with MS/MS techniques. Xenobiotica, 17, 413–422.
   PubMed Web of Science ®Google Scholar
• VRBANAC, J. J., O'LEARY, I. A. and BACZYNSKY J., 1992, Utility of parent-neutral loss scan screening technique: partial characterization of urinary metabolites of U-78875 in monkey urine. Biological Mass Spectrometry, 21, 517–522.
   Google Scholar
• WHETINGTON, P. F., KEHRER, B. H., WHITINGTON S. H., SHNEIDER, B. and BLACK, D. B., 1989, The effect of biliary enteroenteostomy on the pharmacokinetics of enterally administered cyclosporine in rats. Hepatology, 9, 393–397.
   Google Scholar
• YAMAGUCHI, T., OIDA, T., IKEDA, C. and SEKINE, Y., 1986, Intestinal absorption of a /3-adrenergic blocking agent nadolol. III. Nuclear magnetic resonance spectroscopic study on nadolol-sodium cholate micellar complex and intestinal absorption of nadolol derivatives in rats. Chemical and Pharmaceutical Bulletin, 34, 4259–4264.
   PubMed Web of Science ®Google Scholar